来那度胺诱导的套细胞淋巴瘤肿瘤 flare 反应 - Suppr

Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.

作者信息

Eve Heather E, Rule Simon A J

出版信息

Br J Haematol. 2010 Nov;151(4):410-2. doi: 10.1111/j.1365-2141.2010.08376.x. Epub 2010 Sep 29.

DOI:10.1111/j.1365-2141.2010.08376.x

PMID:20880113

Abstract

摘要

相似文献

Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.

Br J Haematol. 2010 Nov;151(4):410-2. doi: 10.1111/j.1365-2141.2010.08376.x. Epub 2010 Sep 29.

Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.

Ann Hematol. 2009 Sep;88(9):921-2. doi: 10.1007/s00277-008-0692-4. Epub 2009 Jan 13.

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.

Br J Haematol. 2009 May;145(3):344-9. doi: 10.1111/j.1365-2141.2009.07626.x. Epub 2009 Feb 24.

Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide.

Eur J Dermatol. 2012 Nov-Dec;22(6):799-800. doi: 10.1684/ejd.2012.1853.

Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?

Am J Hematol. 2011 Nov;86(11):957. doi: 10.1002/ajh.22148.

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.

J Clin Oncol. 2008 Oct 20;26(30):4952-7. doi: 10.1200/JCO.2007.15.3429. Epub 2008 Jul 7.

Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction.

J Am Acad Dermatol. 2011 Sep;65(3):654-656. doi: 10.1016/j.jaad.2010.04.034.

Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.

Am J Hematol. 2010 Jan;85(1):87-90. doi: 10.1002/ajh.21571.

Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.

J Clin Oncol. 2007 Nov 1;25(31):5047. doi: 10.1200/JCO.2007.14.2141.

Lenalidomide for mantle cell lymphoma.

Expert Rev Hematol. 2015 Jun;8(3):257-64. doi: 10.1586/17474086.2015.1035706.

引用本文的文献

Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT.

J Clin Med. 2023 May 16;12(10):3498. doi: 10.3390/jcm12103498.

Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report.

Front Immunol. 2022 Jan 14;12:756583. doi: 10.3389/fimmu.2021.756583. eCollection 2021.

Tumour flare reaction in cancer treatments: a comprehensive literature review.

Anticancer Drugs. 2019 Oct;30(9):953-958. doi: 10.1097/CAD.0000000000000814.

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.

Blood. 2018 Nov 22;132(21):2240-2248. doi: 10.1182/blood-2018-02-835496. Epub 2018 Sep 27.

Approaches to Managing Safety With Lenalidomide in Hematologic Malignancies.

J Adv Pract Oncol. 2014 Jul-Aug;5(4):269-79. doi: 10.6004/jadpro.2014.5.4.4.

Rethinking clinical response and outcome assessment in a biologic age.

Curr Oncol Rep. 2015 Jun;17(6):27. doi: 10.1007/s11912-015-0452-2.

Tumor flare reaction in a patient with mantle cell lymphoma.

Blood Res. 2014 Dec;49(4):279-80. doi: 10.5045/br.2014.49.4.279. Epub 2014 Dec 23.

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study.

Ann Oncol. 2013 Nov;24(11):2892-7. doi: 10.1093/annonc/mdt366. Epub 2013 Sep 12.

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

Br J Haematol. 2011 Nov;155(4):457-67. doi: 10.1111/j.1365-2141.2011.08882.x. Epub 2011 Oct 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献